This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cerner Innovation, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Xinyong Tian: Innovator in Medical Risk Assessment
Introduction
Xinyong Tian is a notable inventor based in Wilmette, Illinois. He has made significant contributions to the field of medical risk assessment through his innovative patent. His work focuses on improving the prediction of potential health events, which can greatly enhance patient care.
Latest Patents
Xinyong Tian holds a patent titled "Reducing the risk of potentially preventable events." This patent involves methods, systems, and computer-storage media designed to determine an individual's second event risk score. The second event risk score represents the likelihood that an individual will experience a second event within a predetermined time period after the occurrence of a first event. Upon the occurrence of the first event, a sampling protocol is initiated. An electronic medical record store is accessed on a predetermined schedule to sample a pre-selected set of medical data elements for the individual. Logistic regression analysis is executed on these data elements to generate the second event risk score. This score is then communicated to a medical professional managing the individual's care, and the electronic medical record is modified to reflect the new risk score.
Career Highlights
Xinyong Tian is associated with Cerner Innovation, Inc., where he applies his expertise in medical technology and data analysis. His work at Cerner has allowed him to contribute to advancements in healthcare technology, particularly in risk assessment methodologies.
Collaborations
Xinyong has collaborated with notable colleagues, including Cole Anthony Erdmann and Timothy J Arnold. These collaborations have further enriched his work and contributed to the development of innovative solutions in the medical field.
Conclusion
Xinyong Tian is a distinguished inventor whose work in medical risk assessment has the potential to transform patient care. His innovative patent demonstrates a commitment to improving healthcare outcomes through technology.